Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 861177 NEW YORK, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,819,887
+$203,455 QoQ
Shares Held
287,158
-7.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 257 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,243 across 206 Biotechnology names. OCUL ranks #88 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,819,887 287,158
2026-03-31 $2,616,432 308,906
2025-12-31 $3,736,045 307,747
2025-09-30 $2,352,717 201,259
2025-06-30 $2,935,040 316,276
2025-03-31 $1,560,936 212,952
2024-12-31 $1,866,740 218,588
2024-09-30 $1,284,850 147,684
2024-06-30 $1,272,650 186,060
2022-03-31 $500,557 101,123
2021-12-31 $551,032 79,058
2021-09-30 $686,210 68,621
2021-06-30 $1,066,619 75,220
2021-03-31 $1,024,771 62,448
2020-12-31 $1,037,835 50,137